252 related articles for article (PubMed ID: 33908291)
1. Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital.
Zeana C; Palmieri FE; Gupta V; Ye G; Lao P; Yu K; Kang KS; Schiller L; Purswani M
Sci Prog; 2021; 104(2):368504211011876. PubMed ID: 33908291
[TBL] [Abstract][Full Text] [Related]
2. Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a pre-authorization policy for fluoroquinolone use: A decade-long experience.
Lee RA; Scully MC; Camins BC; Griffin RL; Kunz DF; Moser SA; Hoesley CJ; McCarty TP; Pappas PG
Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1419-1424. PubMed ID: 30296959
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Stewardship in the Microbiology Laboratory: Impact of Selective Susceptibility Reporting on Ciprofloxacin Utilization and Susceptibility of Gram-Negative Isolates to Ciprofloxacin in a Hospital Setting.
Langford BJ; Seah J; Chan A; Downing M; Johnstone J; Matukas LM
J Clin Microbiol; 2016 Sep; 54(9):2343-7. PubMed ID: 27385708
[TBL] [Abstract][Full Text] [Related]
4. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L
Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557
[No Abstract] [Full Text] [Related]
5. Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China.
Guo W; He Q; Wang Z; Wei M; Yang Z; Du Y; Wu C; He J
Am J Infect Control; 2015 Apr; 43(4):358-64. PubMed ID: 25838134
[TBL] [Abstract][Full Text] [Related]
6. Association between the rate of fluoroquinolones-resistant gram-negative bacteria and antibiotic consumption from China based on 145 tertiary hospitals data in 2014.
Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
BMC Infect Dis; 2020 Apr; 20(1):269. PubMed ID: 32264851
[TBL] [Abstract][Full Text] [Related]
7. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
Hsueh PR; Chen WH; Luh KT
Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
[TBL] [Abstract][Full Text] [Related]
8. Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization.
Brigmon MM; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
Clin Microbiol Infect; 2015 Sep; 21(9):843-9. PubMed ID: 26003282
[TBL] [Abstract][Full Text] [Related]
9. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
[TBL] [Abstract][Full Text] [Related]
10. Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital.
Hwang H; Kim B
Sci Rep; 2018 Oct; 8(1):14757. PubMed ID: 30283084
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial co-resistance patterns of gram-negative bacilli isolated from bloodstream infections: a longitudinal epidemiological study from 2002-2011.
Wong PH; von Krosigk M; Roscoe DL; Lau TT; Yousefi M; Bowie WR
BMC Infect Dis; 2014 Oct; 14():393. PubMed ID: 25308184
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014.
Yang Q; Zhang H; Wang Y; Xu Z; Zhang G; Chen X; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Luo Y; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H; Badal RE
BMC Infect Dis; 2017 Mar; 17(1):192. PubMed ID: 28264656
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance.
Sahm DF; Critchley IA; Kelly LJ; Karlowsky JA; Mayfield DC; Thornsberry C; Mauriz YR; Kahn J
Antimicrob Agents Chemother; 2001 Jan; 45(1):267-74. PubMed ID: 11120976
[TBL] [Abstract][Full Text] [Related]
14. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S
Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419
[TBL] [Abstract][Full Text] [Related]
15. Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals.
Hsu LY; Tan TY; Tam VH; Kwa A; Fisher DA; Koh TH;
Antimicrob Agents Chemother; 2010 Mar; 54(3):1173-8. PubMed ID: 20065055
[TBL] [Abstract][Full Text] [Related]
16. [Quinolone resistance in Gram negative rods in Iceland and association with antibiotic use].
Jónsdóttir K; Kristinsson KG
Laeknabladid; 2008 Apr; 94(4):279-85. PubMed ID: 18460726
[TBL] [Abstract][Full Text] [Related]
17. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
Ishikawa K; Hamasuna R; Uehara S; Yasuda M; Yamamoto S; Hayami H; Takahashi S; Matsumoto T; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Deguchi T; Matsumoto M; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Wakeda H; Amemoto Y; Onodera S; Goto H; Komeda H; Yamashita M; Takenaka T; Fujimoto Y; Tsugawa M; Takahashi Y; Maeda H; Onishi H; Ishitoya S; Nishimura K; Mitsumori K; Ito T; Togo Y; Nakamura I; Ito N; Kanamaru S; Hirose T; Muranaka T; Yamada D; Ishihara S; Oka H; Inatomi H; Matsui T; Kobuke M; Kunishima Y; Kimura T; Ichikawa T; Kagara I; Matsukawa M; Takahashi K; Mita K; Kato M; Okumura K; Kawanishi H; Hashimura T; Aoyama T; Shigeta M; Koda S; Taguchi K; Matsuda Y
J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact.
Shin J; Kim J; Wie SH; Cho YK; Lim SK; Shin SY; Yeom JS; Lee JS; Kweon KT; Lee H; Cheong HJ; Park SH; Park DW; Ryu SY; Chung MH; Yoo S; Pai H
Microb Drug Resist; 2012 Apr; 18(2):169-75. PubMed ID: 22400491
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of flouroquinolone therapy for gram-negative infections within the intensive care unit setting.
Hassoun A; Eiland E
Am J Med; 2006 Jun; 119(6):e7. PubMed ID: 16750952
[No Abstract] [Full Text] [Related]
20. Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Chu Y; Chen S; Cao B; Su J; Duan Q; Zhang S; Shao H; Kong H; Gui B; Hu Z; Badal R; Xu Y
BMC Infect Dis; 2017 Dec; 17(1):776. PubMed ID: 29254478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
